• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1p等位基因缺失与脑膜瘤的肿瘤进展相关。

Allelic loss at 1p is associated with tumor progression of meningiomas.

作者信息

Bello M J, de Campos J M, Kusak M E, Vaquero J, Sarasa J L, Pestaña A, Rey J A

机构信息

Instituto de Investigaciones Biomédicas (CSIC), Madrid, Spain.

出版信息

Genes Chromosomes Cancer. 1994 Apr;9(4):296-8. doi: 10.1002/gcc.2870090411.

DOI:10.1002/gcc.2870090411
PMID:7519053
Abstract

Next to chromosome 22 anomalies, deletions of the short arm of chromosome 1 have previously been described as the most frequent alteration detected by cytogenetic analysis of meningiomas. To determine the incidence of these deletions, we have analyzed a series of 50 meningiomas for the loss of alleles at four chromosome 1 loci. Thirteen samples displayed LOH for the markers studied; in one instance, the results were compatible with loss of the entire chromosome 1, whereas in the other 12 samples deletions of the short arm were observed. Eleven of the meningiomas had previously been shown to have loss of alleles on chromosome 22, and 12 of them were characterized by increased tumor aggressiveness. These findings suggest that deletion of Ip (or the alteration of a locus located there) might represent a secondary, but nonrandom alteration in meningiomas, perhaps contributing to meningioma tumor progression.

摘要

除了22号染色体异常外,1号染色体短臂缺失先前已被描述为通过脑膜瘤细胞遗传学分析检测到的最常见改变。为了确定这些缺失的发生率,我们分析了一系列50例脑膜瘤在4个1号染色体位点上等位基因的缺失情况。13个样本在所研究的标记上显示杂合性缺失;其中1例结果与整个1号染色体缺失相符,而在其他12个样本中观察到短臂缺失。其中11例脑膜瘤先前已显示22号染色体上等位基因缺失,且其中12例具有肿瘤侵袭性增加的特征。这些发现表明,1p缺失(或位于该区域的一个位点的改变)可能代表脑膜瘤中的一种继发性但非随机的改变,可能促进脑膜瘤的肿瘤进展。

相似文献

1
Allelic loss at 1p is associated with tumor progression of meningiomas.1p等位基因缺失与脑膜瘤的肿瘤进展相关。
Genes Chromosomes Cancer. 1994 Apr;9(4):296-8. doi: 10.1002/gcc.2870090411.
2
NF2 gene mutations and allelic status of 1p, 14q and 22q in sporadic meningiomas.散发性脑膜瘤中NF2基因突变及1p、14q和22q的等位基因状态
Oncogene. 1999 Apr 1;18(13):2231-9. doi: 10.1038/sj.onc.1202531.
3
Deletion mapping of the short arm of chromosome 1 identifies a common region of deletion distal to D1S496 in human meningiomas.对1号染色体短臂的缺失定位发现,在人类脑膜瘤中,1号染色体短臂上存在一个常见的缺失区域,该区域位于D1S496远端。
Acta Neuropathol. 1997 Nov;94(5):479-85. doi: 10.1007/s004010050736.
4
Identification of a consistent region of allelic loss on 1p32 in meningiomas: correlation with increased morbidity.脑膜瘤中1p32等位基因缺失一致性区域的鉴定:与发病率增加的相关性
Cancer Res. 1998 Aug 1;58(15):3226-30.
5
Chromosomal deletions in anaplastic meningiomas suggest multiple regions outside chromosome 22 as important in tumor progression.间变性脑膜瘤中的染色体缺失表明22号染色体以外的多个区域在肿瘤进展中很重要。
Int J Cancer. 1994 Feb 1;56(3):354-7. doi: 10.1002/ijc.2910560310.
6
Meningiomas: analysis of loss of heterozygosity on chromosome 10 in tumor progression and the delineation of four regions of chromosomal deletion in common with other cancers.脑膜瘤:肿瘤进展过程中10号染色体杂合性缺失分析以及与其他癌症共有的四个染色体缺失区域的划定
Clin Cancer Res. 2003 Oct 1;9(12):4435-42.
7
Loss of material from chromosome arm 1p during malignant progression of meningioma revealed by fluorescent in situ hybridization.荧光原位杂交显示脑膜瘤恶性进展过程中1号染色体短臂物质的缺失。
Cancer. 1998 Jul 15;83(2):360-6.
8
Allelic losses at 1p, 9q, 10q, 14q, and 22q in the progression of aggressive meningiomas and undifferentiated meningeal sarcomas.侵袭性脑膜瘤和未分化脑膜肉瘤进展过程中1p、9q、10q、14q和22q的等位基因缺失。
Cancer Genet Cytogenet. 1999 Apr 15;110(2):103-10. doi: 10.1016/s0165-4608(98)00209-x.
9
1p and 3p deletions in meningiomas without detectable aberrations of chromosome 22 identified by comparative genomic hybridization.通过比较基因组杂交鉴定出的脑膜瘤中1p和3p缺失,而未检测到22号染色体的畸变。
Genes Chromosomes Cancer. 1997 Dec;20(4):419-24.
10
Comprehensive DNA copy number profiling of meningioma using a chromosome 1 tiling path microarray identifies novel candidate tumor suppressor loci.使用1号染色体平铺路径微阵列对脑膜瘤进行全面的DNA拷贝数分析,鉴定出新的候选肿瘤抑制基因座。
Cancer Res. 2005 Apr 1;65(7):2653-61. doi: 10.1158/0008-5472.CAN-04-3651.

引用本文的文献

1
Loss over 5% of chromosome 1p is a clinically relevant and applicable cut-off for increased risk of recurrence in meningioma.1号染色体短臂缺失超过5%是脑膜瘤复发风险增加的一个具有临床相关性且适用的临界值。
Acta Neuropathol. 2024 Aug 8;148(1):17. doi: 10.1007/s00401-024-02777-z.
2
Genomic Landscape of Meningiomas.脑膜瘤的基因组景观。
Adv Exp Med Biol. 2023;1416:137-158. doi: 10.1007/978-3-031-29750-2_11.
3
Different clinical and cytogenetic features of primary skull base meningiomas and non-skull base meningiomas.原发性颅底脑膜瘤和非颅底脑膜瘤的不同临床和细胞遗传学特征。
J Neurooncol. 2023 Jun;163(2):447-453. doi: 10.1007/s11060-023-04351-1. Epub 2023 Jun 2.
4
Associations of meningioma molecular subgroup and tumor recurrence.脑膜瘤分子亚组与肿瘤复发的关联。
Neuro Oncol. 2021 May 5;23(5):783-794. doi: 10.1093/neuonc/noaa226.
5
High Copy-Number Variation Burdens in Cranial Meningiomas From Patients With Diverse Clinical Phenotypes Characterized by Hot Genomic Structure Changes.具有以热点基因组结构变化为特征的不同临床表型的患者的颅骨脑膜瘤中的高拷贝数变异负担
Front Oncol. 2020 Aug 14;10:1382. doi: 10.3389/fonc.2020.01382. eCollection 2020.
6
Intraventricular meningiomas frequently harbor NF2 mutations but lack common genetic alterations in TRAF7, AKT1, SMO, KLF4, PIK3CA, and TERT.脑室脑膜瘤常携带 NF2 突变,但缺乏 TRAF7、AKT1、SMO、KLF4、PIK3CA 和 TERT 等常见的遗传改变。
Acta Neuropathol Commun. 2019 Aug 30;7(1):140. doi: 10.1186/s40478-019-0793-4.
7
Transcriptome signatures associated with meningioma progression.与脑膜瘤进展相关的转录组特征。
Acta Neuropathol Commun. 2019 Apr 30;7(1):67. doi: 10.1186/s40478-019-0690-x.
8
Molecular and translational advances in meningiomas.脑膜瘤的分子和转化进展。
Neuro Oncol. 2019 Jan 14;21(Suppl 1):i4-i17. doi: 10.1093/neuonc/noy178.
9
Advances in meningioma genetics: novel therapeutic opportunities.脑膜瘤遗传学的进展:新的治疗机会。
Nat Rev Neurol. 2018 Feb;14(2):106-115. doi: 10.1038/nrneurol.2017.168. Epub 2018 Jan 5.
10
Viral Inhibition of the IFN-Induced JAK/STAT Signalling Pathway: Development of Live Attenuated Vaccines by Mutation of Viral-Encoded IFN-Antagonists.病毒对 IFN 诱导的 JAK/STAT 信号通路的抑制:通过突变病毒编码的 IFN 拮抗剂开发减毒活疫苗。
Vaccines (Basel). 2016 Jun 29;4(3):23. doi: 10.3390/vaccines4030023.